Vol 48 No 6

Median overall survival is the same for both malignancies, study results show.

As practices reboot, urologists consider leaner staffs and operations.

Mitomycin sees the largest annual growth in spending per dose over the past 5 years, Robert A. Dowling, MD, reports.

Three codes are available for prostate biopsy, but only one is typically used for perineal biopsy, according to Jonathan Rubenstein, MD, and Mark Painter.